In order to explore the effect of NUTM2A-AS1 on the proliferation and invasion of breast cancer cell lines, we constructed a knockdown plasmid of NUTM2A-AS1 and successfully reduced the expression of NUTM2A-AS1 in breast cancer cells (Figure 2(a)). The gene discussed is NUTM2A; the disease is breast cancer.